A Study of Guselkumab in Adult Participants With Celiac Disease

NCT04704843 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study terminated. Sponsor decision.

Conditions

Celiac Disease

Interventions

DRUG: Guselkumab
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC